Welcome to the MarketReader Minute.

Below are AI-generated insights on today’s premarket moves, powered by MarketReader technology.

If you find the insights useful, you may subscribe to our new sector-specific newsletters or share this on Twitter.

Tuesday, August 5

Noteworthy macro moves today: Ethereum -2.2%. 

Recent developments in the global economy have been significantly influenced by renewed trade tensions, particularly between the United States and India. President Trump has announced increased tariffs on imports from India due to its continued purchases of Russian oil, which is expected to escalate market volatility as these measures take effect soon.

In economic data releases today, the U.S. trade deficit narrowed more than anticipated for June 2025 at $60.2 billion compared to forecasts of a $61.6 billion shortfall; this was driven primarily by a notable decline in imports led by consumer goods such as pharmaceuticals and automobiles. Additionally, Canada reported an increase in its trade deficit for June but showed signs of resilience with exports rising slightly despite ongoing tariff pressures affecting cross-border commerce.

Market sentiment remains cautious yet optimistic following last week's weak jobs report, which has strengthened expectations for Federal Reserve interest rate cuts next month. Futures markets now price in over a 90% probability of policy easing, reflecting growing confidence that the Fed will act amid softening labor conditions across major economies such as Japan and Europe, where central banks are also grappling with inflationary pressures and slowing growth.

Ethereum (ETH/USD) [-2.2%]
Ethereum has dropped significantly today, reflecting broader market sentiment. The cryptocurrency is down approximately 2.2%, coinciding with negative sentiment stemming from President Trump's tariff plans on semiconductors and pharmaceuticals, as well as ongoing trade tensions with India over oil purchases from Russia. Concurrently, expectations of an interest rate cut by the Federal Reserve have risen due to weak labor market data. Social media discussions reveal that whales have increased their holdings by $236 million in Ethereum, accumulating a total of 63,837 ETH through FalconX and Galaxy OTC channels. Additionally, Bitcoin has declined by over 1%, which may also influence Ethereum's price movement given their historical correlation. The recent U.S. Balance of Trade report showed a narrower trade deficit, which typically impacts Ethereum's price dynamics significantly.

BWXT | +13.9% | +2.2B
BWX Technologies Inc | Aerospace & Defense
BWX Technologies Inc reported its second-quarter 2025 results, achieving an adjusted earnings per share (EPS) of 1.02, surpassing the analyst estimate of 0.79 by over 29%. This marks a year-over-year increase from the previous EPS of 0.82. Quarterly sales reached 764.039 million, exceeding the consensus estimate of 707.997 million and reflecting a 12.12% increase from the prior year. The company raised its full-year guidance for adjusted EPS to between 3.65 and 3.75, up from 3.40 to 3.55, and increased its sales forecast to approximately 3.1 billion from 3 billion. Additionally, BWX projected an adjusted EBITDA of 565 million to 575 million and free cash flow between 275 million and 285 million for 2025. Following these announcements, BWXT's stock experienced a notable increase, trading significantly higher in pre-market activity.

PLTR | +7.0% | +26.8B
Palantir Technologies Inc | Application Software
Palantir Technologies reported robust second-quarter earnings, with revenue of $1.004 billion, a 48% increase year-over-year, surpassing analyst estimates of $939.71 million. The adjusted earnings per share (EPS) was $0.16, exceeding the consensus of $0.14. U.S. commercial revenue surged by 93% to $306 million, while U.S. government revenue grew by 53% to $426 million. The company raised its full-year 2025 revenue guidance to between $4.14 billion and $4.15 billion, up from approximately $3.90 billion. Palantir anticipates third-quarter revenue between $1.083 billion and $1.087 billion, significantly above the consensus estimate of $981 million. Following these announcements, shares increased by approximately 4-5% in after-hours trading, reflecting a strong market reaction. The customer count also rose by 43% year-over-year, underscoring substantial growth across its business segments.

HIMS | -10.4% | -1.3B
Hims & Hers Health Inc | Health Care Services
Hims & Hers Health, Inc. reported second-quarter revenue of $544.8 million, missing analyst expectations of $551.6 million, which led to a notable decline in stock price. The company achieved earnings of 17 cents per share, exceeding the forecast of 14 cents. Despite a year-over-year revenue growth of 73%, the negative operating cash flow of $19.1 million and the revenue miss overshadowed these results. The company anticipates third-quarter revenue between $570 million and $590 million, also below some analyst estimates. Additionally, Hims & Hers has seen its partnership with Novo Nordisk dissolve amid allegations of deceptive marketing regarding weight-loss products. Following the earnings report, shares dropped significantly in after-hours trading, with a decline of approximately 11%.

AXON | +7.8% | +4.7B
Axon Enterprise Inc | Aerospace & Defense
Axon Enterprise Inc reported Q2 2025 revenue of $669 million, a 33% year-over-year increase, surpassing the estimated $631.6 million. The adjusted EPS was $2.12, exceeding the consensus estimate of $1.46. Following this, the company raised its FY25 revenue guidance to a range of $2.65 billion to $2.73 billion, slightly above the previous range and in line with the consensus estimate of $2.66 billion. Adjusted EBITDA expectations were also increased to between $665 million and $685 million. Analysts have responded positively, raising their price targets for Axon, including notable upgrades from Baird and Barclays. On social media, discussions highlighted the strong earnings results and significant growth in Software & Services revenue, which rose by 39%. In pre-market trading, AXON was noted to be trading above $800, reflecting continued positive sentiment.

APO | +4.3% | +3.6B
Apollo Global Management Inc | Diversified Financial Services
Apollo Global Management reported strong second-quarter results, with adjusted earnings per share of $1.92, exceeding the analyst consensus estimate of $1.87. This marks a year-over-year increase from $1.64 per share. The company achieved sales of $6.814 billion, significantly surpassing expectations of $4.609 billion, and reflecting a year-over-year increase from $6.018 billion. Adjusted net income reached $1.18 billion, bolstered by record fee-related earnings and robust capital solutions fees. Total assets under management increased by 21% to $840 billion, supported by $61 billion in net inflows. Additionally, social media discussions highlighted the impressive growth in assets under management at a rate exceeding 20% year-over-year.

ZTS | +9.0% | +6.8B
Zoetis Inc | Pharmaceuticals
Zoetis Inc. reported its Q2 2025 results, revealing an adjusted EPS of 1.76, exceeding the consensus estimate of 1.61. Revenue for the quarter reached 2.5 billion, surpassing expectations of 2.41 billion. Following this strong performance, Zoetis raised its full-year 2025 adjusted EPS guidance to a range of 6.30 to 6.40, up from 6.20 to 6.30. The company also increased its revenue forecast to between 9.45 billion and 9.6 billion, compared to prior estimates. Organic operational revenue growth is projected at 6.5% to 8.0%. Social media discussions noted significant upward movement in Zoetis shares, suggesting a trend among quality healthcare stocks that have been undervalued, coinciding with the release of these financial results. Following the earnings announcement, shares moved significantly higher within minutes.

Thank you for spending a minute with us. 

If you have 2 more minutes, watch this demo of the MarketReader Platform: